Common Challenges in Predicting Opioid-related Outcomes Using Machine Learning
Chandan Saha1, Alan Davalos Guzman1, Yutong Li1
1Department of Psychiatry, University of Alberta, Edmonton, AB, Canada.
Substance Use & Addiction Journal
|August 3, 2026
Summary
Machine learning (ML) models show promise for predicting opioid risks but face challenges. Addressing issues like data variability and validation is key to improving their clinical use for opioid-related outcomes.
Area of Science:
- Medical Informatics
- Computational Health
- Data Science in Medicine
Background:
- Machine learning (ML) models are increasingly used to predict opioid-related outcomes such as opioid use disorder (OUD), misuse, and overdose.
- Despite advancements, the clinical utility and comparability of these ML models are limited.
Purpose of the Study:
- To provide an updated overview of the challenges hindering the effective application of ML models in predicting opioid-related outcomes.
- To outline strategies for enhancing the clinical relevance and deployment of ML in this domain.
Main Methods:
- Review and synthesis of current literature on ML applications for opioid-related outcome prediction.
- Identification and categorization of key challenges impacting model performance and clinical utility.
Main Results:
- Key challenges include variability in outcome definitions, data heterogeneity, class imbalance, inadequate validation (external/prospective), and limited real-world deployment.
- Ethical considerations also pose significant constraints on ML model application.
Conclusions:
- Overcoming these challenges is crucial for realizing the full potential of ML in clinical practice for managing opioid-related risks.
- Implementing standardized definitions, robust validation, and addressing ethical concerns will improve ML model reliability and applicability.
Related Concept Videos
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
